- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07942207
Spanish Registry of Cardioneuroablation (SRCNA)
Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes.
Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain.
Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up.
Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021.
Study population
Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes:
- Cardioinhibitory reflex syncope: bradycardia <40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder.
- Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing.
- Functional sinus node dysfunction.
- Functional AV block. Procedure
CNA is performed according to the usual practice of each center. The operator chooses:
- the approach (right atrium, left atrium or both);
- the number of GP targeted;
- the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations);
- the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected
- Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test).
- Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure.
- Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications.
- Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events.
Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up.
Ongoing sub-studies:
- long-term follow-up of these patients and identification of predictors of recurrence;
- redo procedures, in patients requiring more than one CNA;
- patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Maria T Barrio-Lopez, MD PhD
- Numéro de téléphone: +34 655298270
- E-mail: terebarriol@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Jesus Almendral
- E-mail: almendraljesus@gmail.com
Lieux d'étude
-
-
-
Albacete, Espagne
- Recrutement
- Hospital Albacete
-
Alicante, Espagne
- Recrutement
- Hospital General Alicante
-
Contact:
- Jose Luis Ibañez
- E-mail: ppluic77@gmail.com
-
Badajoz, Espagne
- Recrutement
- Hospital Badajoz
-
Barcelona, Espagne
- Recrutement
- Hospital Dexeus Barcelona
-
Contact:
- Ángel Moya
- E-mail: amoyamitjans@gmail.com
-
Barcelona, Espagne
- Recrutement
- Hospital Vall d´Hebron
-
Bilbao, Espagne
- Recrutement
- Hospital de Basurto
-
Contact:
- Jesus Martinez
- E-mail: txules@gmail.com
-
Córdoba, Espagne
- Recrutement
- Hospital Reina Sofia
-
Girona, Espagne
- Recrutement
- Hospital Josep Trueta
-
Granada, Espagne
- Recrutement
- Hospital Virgen de las Nieves
-
Granada, Espagne
- Recrutement
- Hospital Clinico Granada
-
Contact:
- Rosa Macias
- E-mail: rmacias148@msn.com
-
Huelva, Espagne
- Recrutement
- Hospital Juan Ramón Jiménez
-
Madrid, Espagne
- Recrutement
- Hospital Puerta de Hierro
-
Contact:
- Eusebio Garcia Izquierdo
- E-mail: usegij@gmail.com
-
Madrid, Espagne
- Recrutement
- Hospital 12 de Octubre
-
Contact:
- Alvaro Marco, amarco89@hotmail.com
-
Madrid, Espagne
- Recrutement
- Hospital Fundación Jiménez Díaz
-
Madrid, Espagne
- Recrutement
- Hospital Gregorio Marañon
-
Madrid, Espagne
- Recrutement
- Hospital Ramón y Cajal
-
Contact:
- Eduardo Franco
- E-mail: efranco@academiamir.com
-
Madrid, Espagne
- Recrutement
- Hospital Torrejon
-
Contact:
- Teba González
- E-mail: tebagf@gmail.com
-
Navarro, Espagne
- Recrutement
- Hospital Universitario de Navarra
-
Contact:
- Oscar Alcalde
- E-mail: 37053oar@gmail.com
-
Santander, Espagne
- Recrutement
- Hospital Valdecilla
-
Santiago de Compostela, Espagne
- Recrutement
- Hospital Santiago de Compostela
-
Contact:
- Carlos Minguito
- E-mail: carlosminguito@hotmail.es
-
Valencia, Espagne
- Recrutement
- Hospital La Fe
-
Valladolid, Espagne
- Recrutement
- Hospital Valladolid
-
Vigo, Espagne
- Recrutement
- Hospital Álvaro Cunqueiro
-
Vitoria-Gasteiz, Espagne
- Recrutement
- Hospital Txagorritxu
-
Zaragoza, Espagne
- Recrutement
- Hospital Miguel Servet
-
-
Madrid
-
Madrid, Madrid, Espagne, 28660
- Recrutement
- Hospital HM Monteprincipe
-
Contact:
- Teresa Barrio, MD PhD
- Numéro de téléphone: 655298270
- E-mail: terebarriol@gmail.com
-
Madrid, Madrid, Espagne
- Recrutement
- Hospital La Paz
-
Contact:
- Carlos Alvarez
- E-mail: calvarezo@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
patients treated with cardioneuroablation
La description
Inclusion Criteria:
- patients treated with cardioneuroablation
Exclusion Criteria:
-
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
syncope
Délai: From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
recurrence of syncope |
From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Complications
Délai: During procedure and 3 months after
|
Complications |
During procedure and 3 months after
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Manifestations neurologiques
- Maladies du système nerveux
- Manifestations neurocomportementales
- Dysautonomies primaires
- Maladies du système nerveux autonome
- Intolérance orthostatique
- Troubles de la conscience
- Inconscience
- Syncope
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Syncope vasovagale
Autres numéros d'identification d'étude
- SEC2021
- Spanish Society of Cardiology (Autre subvention/numéro de financement: Cardiac Rhythm society)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .